Nextage Therapeutics (XTAE:NXTG) Pre-Tax Income : ₪-4.20 Mil (TTM As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Nextage Therapeutics's pretax income for the six months ended in Dec. 2023 was ₪-1.78 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-4.20 Mil. Nextage Therapeutics's pretax margin was -249.79%.

During the past 8 years, Nextage Therapeutics's highest Pretax Margin was -479.79%. The lowest was -31282.14%. And the median was -4905.01%.

Nextage Therapeutics Pre-Tax Income Historical Data

The historical data trend for Nextage Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Pre-Tax Income Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-4.56

-15.97

-7.93

-5.99

-4.20

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial									-4.99	-2.98	-3.00	-2.42	-1.78

Competitive Comparison of Nextage Therapeutics's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextage Therapeutics's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's Pre-Tax Income falls into.

Nextage Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Nextage Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-3.987	+	0	+	-0.05	+	0	+	-0.166
	=	-4.20

Nextage Therapeutics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.724	+	0	+	0.109	+	0	+	-0.166
	=	-1.78

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-4.20 Mil.

Nextage Therapeutics (XTAE:NXTG) Pre-Tax Income Explanation

Nextage Therapeutics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.781	/	0.713
	=	-249.79%

During the past 8 years, Nextage Therapeutics's highest Pretax Margin was -479.79%. The lowest was -31282.14%. And the median was -4905.01%.

Nextage Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021